QA: Tharimmune Inc. in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001861657_2022_Tharimmune_Inc.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001861657')"}

Graph

Absolute values for 0001861657, Tharimmune Inc.

  xvar xval
0 AssetsCurrent 621,677
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 0
4 LiabilitiesCurrent 4,533,680
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 772,899
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 1,365,214
9 ResearchAndDevelopmentExpense 1,842,803
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 1,001,374
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 621,677
1 Liabilities 5,306,579
2 Expenses 3,208,017
3 Revenues 0
4 StockholdersEquity -4,684,902
5 NetIncome -2,206,643
6 ComprehensiveNetIncome -2,206,643
7 BaseVar 5,068,824
8 EconomicCapitalRatio -3.46

Edgar->Model Mapping

Feature Distribution

Change over Time